- Biologic treatment in glomerular disease2014 | First Faculty of Medicine
- Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases2021 | First Faculty of Medicine
- Glomerular diseases.1998 | Faculty of Physical Education and Sport
- Possibilities of using biological therapy in patients with glomerular disease2012 | First Faculty of Medicine
- Rituximab in the treatment of patients with glomerular disease2011 | First Faculty of Medicine
- Certain Cytokines and Their Possible Role in the Pathogenesis of Glomerular Diseases in Children1998 | Faculty of Medicine in Hradec Králové
- Prevalence of hypertension in glomerular diseases data from the Czech register of renal biopsies2004 | First Faculty of Medicine
- Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy2023 | First Faculty of Medicine
- Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments2014 | First Faculty of Medicine
- Screening for NPHS2 Mutations May Help Predict FSGS Recurrence after Transplantation2011 | Second Faculty of Medicine
- Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children2017 | Second Faculty of Medicine
- Genotype/Phenotype Correlation in Nephrotic Syndrome Caused by WT1 Mutations2010 | Second Faculty of Medicine
- Incidence of arterial hypertension in different types of glomerulopathies in the Czech Registry of renal biopsies (CRRP) in the years 1995-20022004 | First Faculty of Medicine
- Diabetic nephropathy2011 | Third Faculty of Medicine
- Chapter 22 Diabetic Nephropathy2016 | Third Faculty of Medicine
- Heart Tumor in a Girl with Nephrotic Syndrome, a Possible Association or a Rare Coincidence?2024 | Second Faculty of Medicine
- New learnings in diagnostics and treatment of glomerulonephritis2013 | First Faculty of Medicine
- Sparsentan. Dual angiotensin II AT1 receptor blocker and endothelin ETA receptor antagonist, Treatment of focal segmental glomerulosclerosis, Treatment of IgA nephropathy2020 | First Faculty of Medicine
- Complement Inhibition in ANCA-Associated Vasculitis2022 | First Faculty of Medicine
- Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children2019 | Second Faculty of Medicine
- The management of membranous nephropathy-an update2022 | First Faculty of Medicine
- Indication for corticosteroids in IgA nephropathy: validation in the European VALIGA cohort of a treatment score based on the Oxford classification2022 | First Faculty of Medicine
- Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis: Early treatment with plasmapheresis and immunoadsorption should be associated with better prognosis2016 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Multi-population genome-wide association study implicates immune and non-immune factors in pediatric steroid-sensitive nephrotic syndrome2023 | First Faculty of Medicine
- Renal Biopsy in 2015-From Epidemiology to Evidence-Based Indications2016 | First Faculty of Medicine
- Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives2022 | First Faculty of Medicine
- Molecular Profiling in IgA Nephropathy and Focal and Segmental Glomerulosclerosis2018 | First Faculty of Medicine, Central Library of Charles University
- Estimating Time to ESRD in Children With CKD2018 | Second Faculty of Medicine